Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,448,503
-
Share change
-
-2,562,268
-
Total reported value
-
$3,721,080
-
Price per share
-
$1.52
-
Number of holders
-
19
-
Value change
-
-$3,816,835
-
Number of buys
-
7
-
Number of sells
-
13
Institutional Holders of VASCULAR BIOGENICS LTD - COM (VBLT) as of Q1 2019
As of 31 Mar 2019,
VASCULAR BIOGENICS LTD - COM (VBLT) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,448,503 shares.
The largest 10 holders included
CVI Holdings, LLC, SABBY MANAGEMENT, LLC, MORGAN STANLEY, MACQUARIE GROUP LTD, FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., RBF Capital, LLC, ACADIAN ASSET MANAGEMENT LLC, RAYMOND JAMES & ASSOCIATES, Menta Capital LLC, and LADENBURG THALMANN FINANCIAL SERVICES INC..
This page lists
19
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.